REGENXBIO
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell REGENXBIO and other ETFs, options, and stocks.About RGNX
REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381.
RGNX Key Statistics
Stock Snapshot
With a market cap of 475.91M, REGENXBIO(RGNX) trades at $9.25. The stock has a price-to-earnings ratio of -2.46.
On 2026-05-05, REGENXBIO(RGNX) stock moved within a range of $8.96 to $9.64. With shares now at $9.25, the stock is trading +3.2% above its intraday low and -4.0% below the session's peak.
Trading volume for REGENXBIO(RGNX) stock has reached 436.65K, versus its average volume of 571.94K.
Over the past 52 weeks, REGENXBIO(RGNX) stock has traded between a high of $16.19 and a low of $6.89.
Over the past 52 weeks, REGENXBIO(RGNX) stock has traded between a high of $16.19 and a low of $6.89.
Analyst ratings
92%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.